Why Glycolysis Persists After HK2 Knockout
The Five Explanations
| Explanation | Mechanism | Signature |
|---|---|---|
| Isoenzyme compensation | HK1 (or HK3) upregulation or unmasking | HK1 protein rises; total hexokinase activity retained |
| Glycogen supply | G6P from glycogenolysis bypasses hexokinase | Glycogen falls during the experiment; labelling shows glycogen-derived G6P |
| Non-glucose lactate | Glutamine-derived lactate maintains the readout | ¹³C-glutamine labels lactate; glucose-derived lactate falls |
| Clonal selection | Clones with higher glycolytic capacity were selected | Mitochondrial and transporter expression differ from parental |
| Readout artefact | The measurement does not report glycolytic flux | ECAR unchanged but lactate falls, or a normalisation error |
Important distinction. These explanations are not mutually exclusive, and a well-designed paper excludes three of them rather than finding one. The most common combination is HK1 compensation plus selection.
Part 1 — Diagnostic Order
| Step | Measurement | What it rules out |
|---|---|---|
| 1 | HK1, HK2, HK3 protein in parental and knockout | Compensation |
| 2 | Glucose consumption alongside lactate release | Readout artefact; a fall in glucose uptake with unchanged ECAR indicates a measurement problem |
| 3 | ¹³C-glucose to ¹³C-lactate | Carbon source of the lactate |
| 4 | ¹³C-glutamine to ¹³C-lactate | Non-glucose contribution |
| 5 | Glycogen content before and after the flux window | Glycogen-derived supply |
| 6 | Mitochondrial content and transporter expression, knockout versus parental | Clonal selection |
The second step is the cheapest and most often skipped. If glucose consumption falls while ECAR and lactate are unchanged, the result is internally inconsistent, and the assay is the problem.
Part 2 — Hexokinase Compensation in Detail
The four hexokinases differ in kinetics, regulation and localisation.
| Isoform | Km for glucose | Regulation | Note |
|---|---|---|---|
| HK1 | Low (high affinity) | Inhibited by G6P | Widely expressed; often the dominant isoform in lines |
| HK2 | Low | Inhibited by G6P; induced by HIF1A and MYC | Mitochondrial association via VDAC |
| HK3 | Low | Inhibited by G6P | Less studied; can be upregulated |
| HK4 (glucokinase) | High | Not inhibited by G6P; regulated by GKRP | Hepatic and pancreatic |
Caveat on the "HK2 is the glycolytic hexokinase" assumption. HK2 is induced in many tumours and is important in some models, but the dominant isoform at baseline varies. A line with high HK1 will show little effect from HK2 loss, and this is a property of the line rather than a failure of the experiment.
The mitochondrial association adds a second variable: HK2 bound to VDAC has preferential access to mitochondrially generated ATP, and its release changes both glycolysis and apoptosis sensitivity. A knockout removes both the catalytic and the localisation function, which is why a catalytically dead, VDAC-binding mutant is a useful control.
Part 3 — Glycogen and Glutamine as Bypasses
Two substrates can support glycolytic flux or the lactate readout without requiring hexokinase activity on extracellular glucose.
- • Glycogen: glycogenolysis produces glucose-6-phosphate directly, bypassing hexokinase. In cells with glycogen stores, a short flux experiment can be supported entirely by this route. Measuring glycogen before and after the window, or labelling it, tests this.
- • Glutamine: glutamine-derived malate can be converted to pyruvate by malic enzyme, and pyruvate to lactate by LDH. In glutamine-replete medium this can maintain lactate release while glucose-derived lactate falls. The ¹³C-glutamine experiment is the direct test, and it is underused.
Readout note. A lactate measurement in glutamine-replete medium is a measurement of total lactate, not of glycolytic lactate. Studies that vary glutamine without re-measuring lactate attribution risk attributing a glutamine effect to glucose metabolism.
Part 4 — Selection and the Parental Comparison
A constitutive knockout clone has been through single-cell cloning and expansion, which is a selection.
| Feature to compare | Why |
|---|---|
| Doubling time | Faster-growing clones may have higher glycolytic capacity |
| Mitochondrial content (mtDNA, a complex subunit) | Oxidative capacity changes during expansion |
| GLUT and MCT expression | Transport capacity changes |
| Baseline lactate per cell | The comparison is per cell, not per well |
| Passage number | Drift accumulates |
The fifth item is procedural and decisive: a knockout clone at passage 12 compared with a parental stock at passage 4 confounds genotype with passage. Frozen early-passage stocks of both, assayed at the same passage, remove the confound.
Part 5 — When the Knockout Genuinely Does Not Matter
There is a real possibility that HK2 is dispensable for glycolytic flux in a given line.
- • Hexokinase capacity may exceed the flux requirement several-fold, so losing one isoform leaves the step non-limiting.
- • The controlling step may be glucose transport, not phosphorylation, in lines with low GLUT expression.
- • The cell may be using another substrate predominantly, so glucose phosphorylation is a minor flux.
The experiment that distinguishes these from compensation is a titration: reduce glucose supply and measure whether the knockout and parental cells diverge. If flux falls identically with substrate in both, the enzyme was not controlling flux; if the knockout falls earlier, the step was contributing.
Part 6 — Where This Article Connects
This is the troubleshooting counterpart to the enzyme validation article, and it depends on the tracing and assay articles in this cluster for the measurements it recommends. The switch article supplies the rate-versus-partition distinction that keeps the interpretation honest: unchanged glycolysis with a changed partition is a different finding from unchanged glycolysis with unchanged partition.
If you need HK2 knockouts characterised with paralog profiling and glycogen and glutamine attribution, we can scope the design with you.
Contact EDITGENE to request a project consultation or quote.
Scientific scope and validation note
Hexokinase isoform expression, glycogen content and glutamine use vary widely between lines; the explanations here are ranked by frequency, not by likelihood in any specific model.
Unchanged lactate release does not establish unchanged glycolytic flux, and unchanged glycolytic flux does not establish that the knocked-out enzyme is dispensable in other contexts.
Scientific interpretation and experimental design
- • Five explanations, one result. Exclude several, do not pick one.
- • Measure the paralogs. This resolves most cases.
- • Glucose consumption is a consistency check. If it falls while lactate does not, the assay is wrong.
- • Glycogen bypasses hexokinase. Measure it when the window is short.
- • Glutamine makes lactate. Attribute before interpreting.
- • Selection is a confound. Match passage and freeze-back.
- • Titrate substrate. That is the test of control.
Selected references for further reading
- • Patra KC, et al. Hexokinase 2 is required for tumour initiation and maintenance. Cell Metabolism. 2013;18:698–711.
- • Wilson JE. Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function. Journal of Experimental Biology. 2003;206:2049–2057.
- • Mathupala SP, Ko YH, Pedersen PL. Hexokinase-2 bound to mitochondria: cancer's stygian link to the Warburg effect. Seminars in Cancer Biology. 2009;19:17–24.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| PBRM1 Knockout A-549 Cell Line | EDJ0001-K01 | Human | 55193 | Details Get a Quote |
| YTHDC1 Knockout A-549 Cell Line | EDC07652 | Human | 91746 | Details Get a Quote |
| TP53 Knockout HCT 116 Cell Line | EDC07854 | Human | 7157 | Details Get a Quote |
| Sirt2 Knockout MH-S Cell Line | EDJ-KQ78173 | Mouse | 64383 | Details Get a Quote |
| TFE3 Knockout KGN Cell Line | EDJ-KQ48 | Human | 7030 | Details Get a Quote |
| Stub1 Knockout MB49 Cell Line | EDJ-KQ53 | Mouse | 56424 | Details Get a Quote |
| ARID1A Knockout SNK-6 Cell Line | EDJ-KQ64 | Human | 8289 | Details Get a Quote |
| Tet1 Knockout Kupffer Cell Line | EDJ-KQ88 | Mouse | 52463 | Details Get a Quote |
| NR1H3 Knockout HEK293T Cell Line | EDJ-KQ109 | Human | 10062 | Details Get a Quote |
| NR1H2 Knockout HEK293T Cell Line | EDJ-KQ110 | Human | 7376 | Details Get a Quote |
| RPS6KB2 Knockout HEK293 Cell Line | EDJ-KQ125 | Human | 6199 | Details Get a Quote |
| SMAD6 Knockout HEK293 Cell Line | EDJ-KQ126 | Human | 4091 | Details Get a Quote |
| JUN Knockout HEK293 Cell Line | EDJ-KQ176 | Human | 3725 | Details Get a Quote |
| JUN Knockout HEK293T Cell Line | EDJ-KQ184 | Human | 3725 | Details Get a Quote |
| ALKBH5 Knockout HEK293 Cell Line | EDJ-KQ186 | Human | 54890 | Details Get a Quote |
- 1
- 2
- ...
- Next Page »